Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy
Immune checkpoint blockade therapies that target CTLA-4 and PD-1/PD-L1 have ushered in a new era of cancer treatment. Nevertheless, a significant proportion of patients demonstrated primary or acquired resistance. Harnessing gut microbiota has been an emerging novel therapeutic strategy to overcome...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , |
|---|---|
| Format: | Revisão |
| Langue: | anglais |
| Publié: |
2020
|
| Accès en ligne: | https://doi.org/10.1016/j.coph.2020.06.004 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|